Sulfasalazine Market Primed for Growth owing to Increasing Demand of Rheumatoid Arthritis Treatment
Sulfasalazine Market Trends The sulfasalazine market has witnessed significant growth over the past few years owing to increasing prevalence of autoimmune and inflammatory diseases globally. Sulfasalazine is an anti-inflammatory drug used primarily in the treatment of rheumatoid arthritis and inflammatory bowel disease. It works by reducing inflammation and pain in joints and bowel. The drug is available in delayed-release tablets and powder form for oral administration. Its advantages over other anti-inflammatory drugs include minimal side effects, low cost, and prolonged disease remission. The global sulfasalazine market is estimated to be valued at US$ 2.32 Bn in 2024 and is expected to exhibit a CAGR of 18.% over the forecast period 2024 to 2031. Key Takeaways Key players operating in the sulfasalazine market are Ophthotech Corporation, Aptamer Sciences, Inc., Novartis AG, NeoNeuro SAS, Aptagen LLC, Aptus Biotech S.L., AM Biotechnologies, LLC, Base Pair Biotechnologies, V...